Suivre
Olivier Bousiges
Olivier Bousiges
Hôpitaux Universitaire de Strasbourg; ICUBE - Équipe Imagerie Multimodale Intégrative en santé (IMIS
Adresse e-mail validée de unistra.fr - Page d'accueil
Titre
Citée par
Citée par
Année
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
4062013
Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent …
O Bousiges, AP Vasconcelos, R Neidl, B Cosquer, K Herbeaux, ...
Neuropsychopharmacology 35 (13), 2521-2537, 2010
1932010
A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice
S Chatterjee, P Mizar, R Cassel, R Neidl, BR Selvi, DV Mohankrishna, ...
Journal of Neuroscience 33 (26), 10698-10712, 2013
1662013
Acetyltransferases (HATs) as targets for neurological therapeutics
A Schneider, S Chatterjee, O Bousiges, BR Selvi, A Swaminathan, ...
Neurotherapeutics 10 (4), 568-588, 2013
1272013
Epileptic prodromal Alzheimer’s disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer’s disease to an epileptic variant?
B Cretin, F Sellal, N Philippi, O Bousiges, L Di Bitonto, C Martin-Hunyadi, ...
Journal of Alzheimer's Disease 52 (3), 1125-1133, 2016
1112016
Late-life environmental enrichment induces acetylation events and nuclear factor κB-dependent regulations in the hippocampus of aged rats showing improved plasticity and learning
R Neidl, A Schneider, O Bousiges, M Majchrzak, A Barbelivien, ...
Journal of Neuroscience 36 (15), 4351-4361, 2016
872016
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
A Rongve, A Witoelar, A Ruiz, L Athanasiu, C Abdelnour, J Clarimon, ...
Scientific reports 9 (1), 7013, 2019
792019
Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
S Chatterjee, R Cassel, A Schneider‐Anthony, K Merienne, B Cosquer, ...
EMBO Molecular Medicine 10 (11), e8587, 2018
752018
Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning
O Bousiges, R Neidl, M Majchrzak, MA Muller, A Barbelivien, ...
PloS one 8 (3), e57816, 2013
682013
Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients
E Schueller, I Paiva, F Blanc, XL Wang, JC Cassel, AL Boutillier, ...
European neuropsychopharmacology 33, 101-116, 2020
672020
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
S Lehmann, J Dumurgier, S Schraen, D Wallon, F Blanc, E Magnin, ...
Alzheimer's research & therapy 6, 1-9, 2014
602014
Diagnostic value of cerebrospinal fluid biomarkers (Phospho-Tau 181, total-Tau, Aβ 42, and Aβ 40) in prodromal stage of Alzheimer’s disease and dementia with Lewy bodies
O Bousiges, B Cretin, T Lavaux, N Philippi, B Jung, S Hezard, C Heitz, ...
Journal of Alzheimer's Disease 51 (4), 1069-1083, 2016
502016
Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases
A Echaniz-Laguna, O Bousiges, JP Loeffler, AL Boutillier
Current medicinal chemistry 15 (13), 1263-1273, 2008
502008
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage
O Bousiges, S Bombois, S Schraen, D Wallon, MM Quillard, A Gabelle, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (5), 467-475, 2018
432018
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
C Delaby, CE Teunissen, K Blennow, D Alcolea, I Arisi, EB Amar, ...
Alzheimer's & Dementia 18 (10), 1868-1879, 2022
412022
Do we know how to diagnose epilepsy early in Alzheimer's disease?
B Cretin, N Philippi, O Bousiges, L Dibitonto, F Sellal, C Martin-Hunyadi, ...
Revue neurologique 173 (6), 374-380, 2017
382017
The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
C Abdelnour, D Ferreira, K Oppedal, L Cavallin, O Bousiges, LO Wahlund, ...
NeuroImage: Clinical 27, 102333, 2020
322020
Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort
F Blanc, V Bouteloup, C Paquet, M Chupin, F Pasquier, A Gabelle, ...
Alzheimer's research & therapy 14 (1), 96, 2022
282022
Biomarkers of dementia with Lewy bodies: differential diagnostic with Alzheimer’s disease
O Bousiges, F Blanc
International Journal of Molecular Sciences 23 (12), 6371, 2022
242022
Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage
O Bousiges, N Philippi, T Lavaux, A Perret-Liaudet, I Lachmann, ...
Alzheimer's Research & Therapy 12, 1-12, 2020
232020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20